middle.news
How OncoSil Medical’s $15.1M Loss Masks Breakthrough Regulatory Wins and Market Expansion
4:21am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
How OncoSil Medical’s $15.1M Loss Masks Breakthrough Regulatory Wins and Market Expansion
4:21am on Saturday 30th of August, 2025 AEST
Key Points
Net loss widened to $15.1 million despite 127% revenue growth
Secured EU MDR certification and German G-BA approval
Completed recruitment in pivotal PANCOSIL and TRIPP-FFX clinical trials
Raised over $14 million through placements and share purchase plans
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Oncosil Medical (ASX:OSL)
OPEN ARTICLE